• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 91 Day 2 on April 2; Register to live stream

    4/1/26 7:00:00 AM ET
    $AEMD
    $ATCH
    $BESS
    $CIA
    Medical/Dental Instruments
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $AEMD alert in real time by email

    MIAMI, April 01, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 91st Emerging Growth Conference on April 1 & 2, 2026.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    For updates, follow us on Twitter

    Day 1 – Presenting Today

    Wednesday, April 1, 2026

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:30

    Introduction

    9:40 – 10:10

    Vislink Technologies, Inc. (OTCQB:VISL)

    Keynote speaker: Carleton Mickey Miller, CEO

    10:50 – 11:20

    First Phosphate Corp. (CSE:PHOS) (OTCQX:FRSPF) (FSE: KD0)

    Keynote speaker: John Passalacqua, CEO

    11:25 – 11:55

    ZTEST Electronics Inc., (OTCID: ZTSTF) (CSE:ZTE)

    Keynote speaker: Steve Smith, President & CEO

    12:00 – 12:30

    NioCorp Developments, Ltd. (NASDAQ:NB)

    Keynote speaker: Mark Smith, Chairman & CEO

    12:35 – 1:05

    Perpetuals.com Ltd (NASDAQ:PDC)

    Keynote Speaker: Patrick Gruhn, CEO

    1:10 – 1:40

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest, CEO

    1:45 – 2:15

    Nova Minerals Limited (NASDAQ:NVA) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    2:20 – 2:50

    Lahontan Gold Corp. (TSXV:LG) (OTCQB:LGCXF)

    Keynote speaker: Kimberly Ann, President / CEO



    2:55 – 3:05

    Tivic Health Systems, Inc.'s (NASDAQ:TIVC)

    Keynote speaker: Michael Handley, CEO



    3:10 – 3:20

    Digi Power X, Inc. (NASDAQ:DGXX)

    Keynote speaker: Michel Amar, CEO

    3:25 – 3:35

    Kneat.com, Inc., (OTCQX:KSIOF) (TSX:KSI)

    Keynote speaker: Edmund Ryan, CEO

    3:40 – 3:50

    Thiogenesis Therapeutics, Corp. (TSXV:TTI) (OTCQX:TTIPF)

    Keynote speaker: Brook Riggins, CFO

    4:10 – 4:20

    Argenica Therapeutics Limited (ASX: AGN)

    Keynote speaker: Dr. Liz Dallimore, CEO & Managing Director



    4:25 – 4:35

    OSR Holdings, Inc. (NASDAQ:OSRH)

    Keynote speakers: Tim Smith

    Day 2 – Presenting Tomorrow

    Thursday, April 2, 2026

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Stakeholder Gold Corp. (OTCQB:SKHRF) (TSXV:SRC)

    Keynote speaker: Christopher James Berlet, President, CEO & Director

    Postponed

    ConnectM Technology Solutions, Inc. (OTCQX:CNTM)

    Keynote speaker: Nayeem Hussain, President of Corporate Development

    10:15 – 10:45

    Jupiter Neurosciences, Inc. (NASDAQ:JUNS) 

    Keynote speaker: Christer Rosén, Chairman & CEO

    10:50 – 11:20

    Newton Golf (NASDAQ:NWTG)

    Keynote speaker: Jeffery R. Clayborne, COO

    Postponed

    Kobo Resources, Inc. (OTC:KBRIF) (TSXV:KRI)

    Keynote speaker: Edouard Gosselin, CEO & Paul Sarjeant, President and COO



    12:00 – 12:30

    Oroco Resource Corp. (OTCQB:ORRCF) (TSXV:OCO)

    Keynote speaker: Ian Graham, President, & Adam Smith, Communications

    12:35 – 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden, VP Corporate Development

    1:10 – 1:40

    VisionWave Holdings, Inc. (NASDAQ:VWAV)

    Keynote speaker: Douglas Landers Davis, Executive Chairman & Interim CEO

    1:45 – 2:15

    Bimergen Energy Corporation (NYSE:BESS)

    Keynote speaker: Bob Brilon, Co-CEO & CFO

    2:20 – 2:50

    Forum Energy Technologies, Inc. (NYSE:FET)

    Keynote speakers: Neal A. Lux, CEO, & David Lyle Williams, CFO

    2:55 – 3:05

    Mawson Infrastructure Group, Inc. (NASDAQ:MIGI)

    Keynote speaker: Kaliste Saloom, Interim CEO



    3:10 - 3:20

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    3:25 – 3:35

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    3:40 – 3:50

    CopAur Minerals, Inc. (OTCQB:COPAF) (TSXV:CPAU)

    Keynote speaker: Andrew Neale, CEO

    3:55 – 4:05

    Stallion Uranium Corp. (OTCQB:STLNF) (TSXV:STUD)

    Keynote speaker: Matthew C. Schwab, CEO & Director

    4:10 – 4:20

    AtlasClear Holdings, Inc. (NYSE:ATCH)

    Keynote speaker: Craig Ridenhour, President & John Schaible, Chairman and CEO

    4:25 – 4:35

    Impact Minerals Limited, (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    4:40 – 4:50

    Aethlon Medical (NASDAQ:AEMD)

    Keynote speaker: Jim Frakes, CEO & CFO

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $ATCH
    $BESS
    $CIA

    CompanyDatePrice TargetRatingAnalyst
    NioCorp Developments Ltd.
    $NB
    6/9/2026$12.00Buy
    B. Riley Securities
    NioCorp Developments Ltd.
    $NB
    10/20/2025Outperform
    William Blair
    Digi Power X Inc. Subordinate Voting Shares
    $DGXX
    9/2/2025$3.50Buy
    Alliance Global Partners
    Aethlon Medical Inc.
    $AEMD
    7/7/2025$1.50Neutral
    H.C. Wainwright
    Mawson Infrastructure Group Inc.
    $MIGI
    3/30/2022$12.00Overweight
    Cantor Fitzgerald
    Vista Gold Corp
    $VGZ
    7/26/2021$3.25 → $3.00Buy
    HC Wainwright & Co.
    Citizens Inc.
    $CIA
    7/19/2021$6.70 → $8.40Neutral → Buy
    Goldman Sachs
    Aethlon Medical Inc.
    $AEMD
    6/25/2021$5.00 → $9.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $AEMD
    $ATCH
    $BESS
    $CIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gerteisen Christopher bought $13,848 worth of shares (2,007 units at $6.90), increasing direct ownership by 1% to 143,698 units (SEC Form 4)

    4 - Nova Minerals Corp (0001852551) (Issuer)

    7/17/26 4:54:12 PM ET
    $NVA
    Precious Metals
    Basic Materials

    SEC Form 4 filed by CFO and General Counsel Patel Sandip I

    4 - AtlasClear Holdings, Inc. (0001963088) (Issuer)

    7/16/26 8:21:33 PM ET
    $ATCH
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Director Carlson Steven J.

    4 - AtlasClear Holdings, Inc. (0001963088) (Issuer)

    7/16/26 8:17:13 PM ET
    $ATCH
    Finance: Consumer Services
    Finance

    $AEMD
    $ATCH
    $BESS
    $CIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

    Transaction expands Jupiter into a dual clinical-stage CNS company by adding a differentiated FDA-designated Novel Chemical Entity alongside its Phase II Parkinson’s disease program JUPITER, FL, July 21, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) today announced that it has entered into a definitive license agreement with PharmAla Biotech Holdings Inc. for perpetual exclusive U.S. rights to ALA-002. The transaction has a potential value of up to $100 million, including milestone payments, and expands Jupiter from a single-program company into a dual clinical-stage CNS developer. Management believes the transaction strengthens the Company through diversification acr

    7/21/26 7:13:00 AM ET
    $JUNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

    TORONTO, July 21, 2026 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. ("PharmAla" or the "Company") (CSE:MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has entered into a definitive license agreement (the "Agreement") on July 20th, 2026 with Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter"), under which PharmAla has granted Jupiter an exclusive, perpetual, royalty-bearing license to develop, manufacture and commercialize ALA-002, PharmAla’s lead drug candidate, in the United States. PharmAla retains all rights to ALA-002 outside the United

    7/21/26 7:00:00 AM ET
    $JUNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VisionWave Files Provisional Patent Application for GhostSight™, a Hybrid Passive Radar Architecture Using Intelligent Cooperative Illumination

    SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (NASDAQ:VWAV) (the "Company" or "VisionWave") today announced the filing of a provisional patent application number 64/111,834 with the United States Patent and Trademark Office covering GhostSight™, a proposed radar and RF sensing architecture designed to enhance detection, tracking, classification, and situational awareness across defense, security, critical-infrastructure, maritime, and airspace-protection environments. GhostSight™ is designed as a hybrid passive radar system that may use both existing environmental RF signals and VisionWave-controlled cooperative illumination sources to detect and interpret objects

    7/17/26 8:00:00 AM ET
    $VWAV
    Computer Software: Prepackaged Software
    Technology

    $AEMD
    $ATCH
    $BESS
    $CIA
    SEC Filings

    View All

    SEC Form 424B3 filed by Jupiter Neurosciences Inc.

    424B3 - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)

    7/21/26 4:07:26 PM ET
    $JUNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jupiter Neurosciences Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - JUPITER NEUROSCIENCES, INC. (0001679628) (Filer)

    7/21/26 4:05:31 PM ET
    $JUNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VisionWave Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - VisionWave Holdings, Inc. (0002038439) (Filer)

    7/21/26 6:09:00 AM ET
    $VWAV
    Computer Software: Prepackaged Software
    Technology

    $AEMD
    $ATCH
    $BESS
    $CIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on NioCorp Developments Ltd. with a new price target

    B. Riley Securities initiated coverage of NioCorp Developments Ltd. with a rating of Buy and set a new price target of $12.00

    6/9/26 7:50:22 AM ET
    $NB
    Metal Mining
    Basic Materials

    William Blair initiated coverage on NioCorp Developments Ltd.

    William Blair initiated coverage of NioCorp Developments Ltd. with a rating of Outperform

    10/20/25 8:45:55 AM ET
    $NB
    Metal Mining
    Basic Materials

    Alliance Global Partners initiated coverage on Digi Power X Inc. with a new price target

    Alliance Global Partners initiated coverage of Digi Power X Inc. with a rating of Buy and set a new price target of $3.50

    9/2/25 8:13:53 AM ET
    $DGXX
    Finance: Consumer Services
    Finance

    $AEMD
    $ATCH
    $BESS
    $CIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Gerteisen Christopher bought $13,848 worth of shares (2,007 units at $6.90), increasing direct ownership by 1% to 143,698 units (SEC Form 4)

    4 - Nova Minerals Corp (0001852551) (Issuer)

    7/17/26 4:54:12 PM ET
    $NVA
    Precious Metals
    Basic Materials

    Principal Financial Officer Choudhury Mahesh bought $31,766 worth of shares (3,622 units at $8.77), increasing direct ownership by 10% to 40,814 units (SEC Form 4)

    4 - ConnectM Technology Solutions, Inc. (0001895249) (Issuer)

    7/13/26 10:28:42 AM ET
    $CNTM
    Engineering & Construction
    Consumer Discretionary

    Amendment: Large owner Endeavor Blockchain, Llc bought $16,700,000 worth of Series D Convertible Preferred Stock (16,700 units at $1,000.00) (SEC Form 4)

    4/A - Big Digital Energy, Inc. (0001218683) (Issuer)

    7/10/26 6:08:09 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $AEMD
    $ATCH
    $BESS
    $CIA
    Leadership Updates

    Live Leadership Updates

    View All

    Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson

    Former White House Council of Economic Advisors Brings Extensive Government, Academic, and Private Sector Experience to Advance Company's Strategic Growth JUPITER, FL, July 07, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS) ("Jupiter Neurosciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced the appointment of Tomas J. Philipson, Ph.D., a distinguished health care economist and former Acting Chairman of the White House Council of Economic Advisers, to its Board of Directors, effective June 26, 2026. Dr. Philipson will serve on both the Audit Committee and Compensation Committee, bringing unparalleled expertise in health economics, reg

    7/7/26 8:58:00 AM ET
    $JUNS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VisionWave Appoints Former UK Member of Parliament Ben Everitt’s Stratonex Defence Technologies as Strategic UK and European Commercialization Partner

    WEST HOLLYWOOD, Calif., July 02, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (NASDAQ:VWAV) ("VisionWave" or the "Company"), a defense technology company developing advanced AI-powered defense, security and autonomous systems, today announced that it has entered into a strategic Distributor Agreement with Stratonex Defence Technologies Ltd., a United Kingdom-based defense technology company co-founded by former Member of Parliament Ben Everitt. Under the agreement, Stratonex will serve as VisionWave’s strategic commercialization, integration and sovereign delivery partner for the United Kingdom, Europe and other mutually agreed markets. The collaboration is designed to expand Vision

    7/2/26 8:00:00 AM ET
    $VWAV
    Computer Software: Prepackaged Software
    Technology

    Nova Minerals Appoints Former JP Morgan Metals & Mining Professional to Board as Company Advances U.S. Critical Metals Strategy

    Anchorage, Alaska, July 01, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Corp ("Nova Minerals" or the "Company") is pleased to announce the appointment of Mr. Joshua Girnun to the Company’s Board of Directors, effective July 1, 2026. Mr. Girnun brings institutional finance and risk underwriting experience from his background at JP Morgan Chase & Co., where he co-founded a client-facing risk underwriting team covering the metals and mining, energy, renewables, industrials, oil and gas, and agriculture sectors. He pairs his financial background with strong technical training, holding two master’s degrees spanning resource finance and geosciences, in addition to an honours degree and a bachelor’s i

    7/1/26 6:30:00 AM ET
    $NVA
    Precious Metals
    Basic Materials

    $AEMD
    $ATCH
    $BESS
    $CIA
    Financials

    Live finance-specific insights

    View All

    Forum Energy Technologies Announces Timing of Second Quarter 2026 Earnings Conference Call

    Forum Energy Technologies, Inc. (NYSE:FET) announced today that it will host its second quarter 2026 earnings conference call at 10:00 a.m. Central Time on Friday, July 31, 2026. FET will issue a press release reporting its second quarter 2026 earnings prior to the conference call. The call will be webcast through the Investor Relations link on FET’s website at ir.f-e-t.com. Participants may also join the call by registering here. A replay of the call will be available on the Investor Relations website after the completion of the call at approximately 5:00 p.m. Central Time. FET is a global manufacturing company, serving the oil, natural gas, defense, and renewable energy industries. Wi

    7/13/26 4:30:00 PM ET
    $FET
    Oil and Gas Field Machinery
    Consumer Discretionary

    Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update

    Australian oncology study advances into Cohort 3 as enrollment continuesEntered the third and final dosing cohort of the Australian oncology study, expanded the Hemopurifier intellectual property portfolio, and maintained a focus on managing operating expenses.Conference Call Today at 4:30 p.m. ETSAN DIEGO, June 10, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a clinical-stage medical therapeutic company focused on developing products to treat cancer and life-threatening viral infections for which there is no treatment, today reported financial results for its fiscal year ended March 31, 2026, and provided an update on recent developments.  Key Highlight

    6/10/26 4:15:00 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

    SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal year end March 31, 2026, at 4:15 p.m. ET on Wednesday, June 10, 2026. Management will host a conference call on Wednesday, June 10, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session.Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10209612/1042263e8ec. Please note t

    6/2/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $AEMD
    $ATCH
    $BESS
    $CIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ConnectM Technology Solutions Inc.

    SC 13G/A - ConnectM Technology Solutions, Inc. (0001895249) (Subject)

    11/14/24 5:36:22 PM ET
    $CNTM
    Engineering & Construction
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by AtlasClear Holdings Inc.

    SC 13D/A - AtlasClear Holdings, Inc. (0001963088) (Subject)

    11/14/24 5:00:29 PM ET
    $ATCH
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by ConnectM Technology Solutions Inc.

    SC 13G - ConnectM Technology Solutions, Inc. (0001895249) (Subject)

    11/14/24 2:33:42 PM ET
    $CNTM
    Engineering & Construction
    Consumer Discretionary